Skip to main content
. Author manuscript; available in PMC: 2013 Sep 19.
Published in final edited form as: Dig Dis Sci. 2010 Apr 22;55(12):3602–3609. doi: 10.1007/s10620-010-1213-6

Table 1.

Characteristics of the study population and bivariate analysis of patients who received ERCP versus those who did not

Total population (n = 132) Any ERCP (n = 59) No ERCP (n = 73) P for any ERCP versus no ERCP
Recipient characteristics
Mean age at transplant (years) 52.8 ± 8.9 53.3 ± 8.6 52.4 ± 9.2 0.54
Male, n (%) 91 (69) 42 (71) 49 (67) 0.62
Caucasian, n (%) 96 (73) 40 (78) 56 (76) 0.25
Indication for transplant, n (%)
 AHF 3 (2) 2 (3) 1 (1)
 Viral 51 (39) 22 (37) 29 (40) 0.50
 ETOH 15 (11) 9 (15) 6 (8)
 Other 63 (48) 26 (44) 37 (51)
MELD score 24.8 ± 7.1 25.7 ± 7.3 24.0 ± 7.0 0.16
Donor characteristics
Male donor, n (%) 74 (60) 36 (64) 38 (57) 0.39
Donor age (years) 35.7 ± 15.0 35.1 ± 14.8 36.1 ± 15.3 0.72
Donor type
 Cadaveric 108 (82) 61 (83) 47 (80) 0.50
 DCD 23 (17) 11 (15) 12 (20)
 Unknown 1 (1) 1 (1) 0 (0)
Donor cause of death, n (%)
 Anoxia 9 (7) 5 (9) 4 (6)
 Cerebral vascular accident (CVA) 48 (39) 22 (39) 26 (38) 0.91
 Trauma 62 (50) 27 (48) 35 (51)
 Unknown 5 (4) 2 (4) 3 (4)
Operative characteristics
Warm ischemia time, min 40.5 ± 10.8 40.5 ± 12.9 40.5 ± 8.8 0.99
Cold ischemia time, min 419.3 ± 121.3 430 ± 122 411 ± 121 0.38
Required retransplant, n (%) 12 (9) 0 (0) 12 (16) 0.001
Survival
Graft survival, %
 1 year 81 92.8 69.3 <0.0001
 3 years 74 90.4 60.8
Patient survival, %
 1 year 85 92.8 77.5 0.01
 3 years 81 90.4 74.7
Patient cause of death, n (%)
 Graft failure/1* liver disease 2 1 (20) 1 (6)
 Infection/sepsis 2 0 (0) 2 (11)
 Cardiac 4 0 (0) 4 (22) 0.34
 Biliary complication 4 2 (40) 2 (11)
 Other 11 2 (40) 9 (50)